Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 431

1.

The Bony Obliteration Tympanoplasty in Pediatric Cholesteatoma: Long-term Hearing Results.

van Dinther JJS, Coopman R, Vercruysse JP, Somers T, Zarowski A, Vanspauwen R, Maryn Y, Cremers CWRJ, Offeciers FE.

Otol Neurotol. 2018 Jul;39(6):715-723. doi: 10.1097/MAO.0000000000001846.

PMID:
29889781
2.

Short-term results from seventy-six patients receiving a bone-anchored hearing implant installed with a novel minimally invasive surgery technique.

Johansson ML, Stokroos RJ, Banga R, Hol MK, Mylanus EA, Savage Jones H, Tysome JR, Vannucchi P, Hof JR, Brunings JW, van Tongeren J, Lutgert RW, Banerjee A, Windfuhr JP, Caruso A, Giannuzzi AL, Bordin S, Hanif J, Schart-Morén N, Singam S, Jonhede S, Holmberg M, Cremers CW, Hultcrantz M.

Clin Otolaryngol. 2017 Oct;42(5):1043-1048. doi: 10.1111/coa.12803. Epub 2017 Jan 4. No abstract available.

PMID:
27930877
3.

A combination of two truncating mutations in USH2A causes more severe and progressive hearing impairment in Usher syndrome type IIa.

Hartel BP, Löfgren M, Huygen PL, Guchelaar I, Lo-A-Njoe Kort N, Sadeghi AM, van Wijk E, Tranebjærg L, Kremer H, Kimberling WJ, Cremers CW, Möller C, Pennings RJ.

Hear Res. 2016 Sep;339:60-8. doi: 10.1016/j.heares.2016.06.008. Epub 2016 Jun 16.

PMID:
27318125
4.

Active Middle Ear Implantation: Long-term Medical and Technical Follow-up, Implant Survival, and Complications.

Zwartenkot JW, Mulder JJ, Snik AF, Cremers CW, Mylanus EA.

Otol Neurotol. 2016 Jun;37(5):513-9. doi: 10.1097/MAO.0000000000001015.

PMID:
27023016
5.

Visual Prognosis in USH2A-Associated Retinitis Pigmentosa Is Worse for Patients with Usher Syndrome Type IIa Than for Those with Nonsyndromic Retinitis Pigmentosa.

Pierrache LH, Hartel BP, van Wijk E, Meester-Smoor MA, Cremers FP, de Baere E, de Zaeytijd J, van Schooneveld MJ, Cremers CW, Dagnelie G, Hoyng CB, Bergen AA, Leroy BP, Pennings RJ, van den Born LI, Klaver CC.

Ophthalmology. 2016 May;123(5):1151-60. doi: 10.1016/j.ophtha.2016.01.021. Epub 2016 Feb 27.

PMID:
26927203
6.

The Bony Obliteration Tympanoplasty in Pediatric Cholesteatoma: Long-term Safety and Hygienic Results.

van Dinther JJ, Vercruysse JP, Camp S, De Foer B, Casselman J, Somers T, Zarowski A, Cremers CW, Offeciers E.

Otol Neurotol. 2015 Sep;36(9):1504-9. doi: 10.1097/MAO.0000000000000851.

PMID:
26375973
7.

Bone-anchored hearing implants in single-sided deafness patients: Long-term use and satisfaction by gender.

Faber HT, Nelissen RC, Kramer SE, Cremers CW, Snik AF, Hol MK.

Laryngoscope. 2015 Dec;125(12):2790-5. doi: 10.1002/lary.25423. Epub 2015 Jul 7.

PMID:
26152833
8.

Long-term Compliance and Satisfaction With Percutaneous Bone Conduction Devices in Patients With Congenital Unilateral Conductive Hearing Loss.

Nelissen RC, Mylanus EA, Cremers CW, Hol MK, Snik AF.

Otol Neurotol. 2015 Jun;36(5):826-33. doi: 10.1097/MAO.0000000000000765.

PMID:
25853613
9.

A Retrospective Cohort Study on the Influence of Comorbidity on Soft Tissue Reactions, Revision Surgery, and Implant Loss in Bone-anchored Hearing Implants.

den Besten CA, Nelissen RC, Peer PG, Faber HT, Dun CA, de Wolf MJ, Kunst HP, Cremers CW, Mylanus EA, Hol MK.

Otol Neurotol. 2015 Jun;36(5):812-8. doi: 10.1097/MAO.0000000000000745.

PMID:
25811351
10.

Response to letter to the editor concerning: Bone-anchored hearing implant loading at three weeks: stability and tolerability after six months.

Faber HT, Nelissen RC, Dun CA, Mylanus EA, Cremers CW, Hol MK.

Otol Neurotol. 2014 Jan;35(1):189-90. doi: 10.1097/MAO.0000000000000180. No abstract available.

PMID:
24317218
11.

Amplification options in unilateral aural atresia: an active middle ear implant or a bone conduction device?

Agterberg MJ, Frenzel H, Wollenberg B, Somers T, Cremers CW, Snik AF.

Otol Neurotol. 2014 Jan;35(1):129-35. doi: 10.1097/MAO.0b013e31829b579f.

PMID:
23988995
12.

Active middle ear implantation for patients with sensorineural hearing loss and external otitis: long-term outcome in patient satisfaction.

Zwartenkot JW, Hashemi J, Cremers CW, Mulder JJ, Snik AF.

Otol Neurotol. 2013 Jul;34(5):855-61. doi: 10.1097/MAO.0b013e31828f47c2.

PMID:
23739560
13.

Familial aggregation of pure tone hearing thresholds in an aging European population.

Hendrickx JJ, Huyghe JR, Topsakal V, Demeester K, Wienker TF, Laer LV, Eyken EV, Fransen E, Mäki-Torkko E, Hannula S, Parving A, Jensen M, Tropitzsch A, Bonaconsa A, Mazzoli M, Espeso A, Verbruggen K, Huyghe J, Huygen PL, Kremer H, Kunst SJ, Diaz-Lacava AN, Steffens M, Pyykkö I, Dhooge I, Stephens D, Orzan E, Pfister MH, Bille M, Sorri M, Cremers CW, Camp GV, de Heyning PV.

Otol Neurotol. 2013 Jul;34(5):838-44. doi: 10.1097/MAO.0b013e318288646a.

PMID:
23739559
14.

Otological aspects and surgical outcome in a consanguineous family with a novel ANKH gene mutation.

Thomeer HG, Morava E, Verbist BM, Cremers CW.

Int J Pediatr Otorhinolaryngol. 2013 Jul;77(7):1152-7. doi: 10.1016/j.ijporl.2013.04.028. Epub 2013 May 31.

PMID:
23726953
15.

Bilateral bone conduction devices: improved hearing ability in children with bilateral conductive hearing loss.

Dun CA, Agterberg MJ, Cremers CW, Hol MK, Snik AF.

Ear Hear. 2013 Nov-Dec;34(6):806-8. doi: 10.1097/AUD.0b013e318291784e.

PMID:
23698625
16.

Comparison between a new implantable transcutaneous bone conductor and percutaneous bone-conduction hearing implant.

Hol MK, Nelissen RC, Agterberg MJ, Cremers CW, Snik AF.

Otol Neurotol. 2013 Aug;34(6):1071-5. doi: 10.1097/MAO.0b013e3182868608.

PMID:
23598702
17.

Clinical aspects of an autosomal dominantly inherited hearing impairment linked to the DFNA60 locus on chromosome 2q23.1-2q23.3.

van Beelen E, Schraders M, Huygen PL, Oostrik J, Plantinga RF, van Drunen W, Collin RW, Kooper DP, Pennings RJ, Cremers CW, Kremer H, Kunst HP.

Hear Res. 2013 Jun;300:10-7. doi: 10.1016/j.heares.2013.03.007. Epub 2013 Mar 26.

PMID:
23538131
18.

Temporal bone imaging in osteogenesis imperfecta patients with hearing loss.

Swinnen FK, Casselman JW, De Leenheer EM, Cremers CW, Dhooge IJ.

Laryngoscope. 2013 Aug;123(8):1988-95. doi: 10.1002/lary.23963. Epub 2013 Feb 12.

PMID:
23404366
19.

Analysis of factors predicting the success of the bone conduction device headband trial in patients with single-sided deafness.

Faber HT, Kievit H, de Wolf MJ, Cremers CW, Snik AF, Hol MK.

Arch Otolaryngol Head Neck Surg. 2012 Dec;138(12):1129-35. doi: 10.1001/jamaoto.2013.754.

PMID:
23247232
20.

Bone-anchored hearing implant loading at 3 weeks: stability and tolerability after 6 months.

Faber HT, Dun CA, Nelissen RC, Mylanus EA, Cremers CW, Hol MK.

Otol Neurotol. 2013 Jan;34(1):104-10. doi: 10.1097/MAO.0b013e318277a282.

PMID:
23202148

Supplemental Content

Loading ...
Support Center